Group One Trading, L.P. Biocryst Pharmaceuticals Inc Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.89 - $7.65 $71,472 - $111,812	14,616 Added 46.51%	46,044 $233,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $97,294 - $132,265	19,537 Added 164.3%	31,428 $188,000
Q3 2023 Nov 09, 2023	BUY	$6.71 - $7.92 $79,788 - $94,176	11,891 New	11,891 $84,000
Q1 2023 May 12, 2023	SELL	$7.94 - $11.84 $488,881 - $729,012	-61,572 Reduced 37.88%	100,976 $842,000
Q4 2022 Feb 09, 2023	BUY	$10.5 - $14.2 $957,327 - $1.29 Million	91,174 Added 127.74%	162,548 $1.87 Million
Q3 2022 Nov 09, 2022	SELL	$10.79 - $14.81 $810,026 - $1.11 Million	-75,072 Reduced 51.26%	71,374 $899,000
Q2 2022 Aug 11, 2022	BUY	$7.89 - $17.88 $1.16 Million - $2.62 Million	146,446 New	146,446 $1.55 Million
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $1.6 Million - $2.74 Million	-138,644 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.18 - $15.46 $239,911 - $331,756	21,459 Added 18.31%	138,644 $1.92 Million
Q3 2021 Nov 12, 2021	BUY	$14.21 - $17.65 $1.67 Million - $2.07 Million	117,185 New	117,185 $1.68 Million
Q2 2021 Aug 10, 2021	SELL	$9.5 - $17.24 $1.18 Million - $2.13 Million	-123,699 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$7.37 - $13.61 $680,442 - $1.26 Million	-92,326 Reduced 42.74%	123,699 $1.26 Million
Q4 2020 Feb 10, 2021	BUY	$3.37 - $8.61 $266,391 - $680,603	79,048 Added 57.71%	216,025 $1.61 Million
Q3 2020 Nov 12, 2020	BUY	$3.43 - $5.53 $186,770 - $301,119	54,452 Added 65.98%	136,977 $471,000
Q2 2020 Aug 13, 2020	BUY	$1.9 - $5.61 $156,797 - $462,965	82,525 New	82,525 $393,000
Q1 2020 May 13, 2020	SELL	$1.6 - $4.11 $8,892 - $22,843	-5,558 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$1.59 - $3.45 $3,932 - $8,531	2,473 Added 80.16%	5,558 $19,000
Q3 2019 Nov 12, 2019	SELL	$2.5 - $3.73 $253,012 - $377,494	-101,205 Reduced 97.04%	3,085 $9,000
Q2 2019 Aug 09, 2019	BUY	$2.91 - $9.15 $295,277 - $928,450	101,470 Added 3598.23%	104,290 $395,000
Q1 2019 May 13, 2019	BUY	$7.38 - $9.72 $20,811 - $27,410	2,820 New	2,820 $23,000
Q4 2018 Feb 06, 2019	SELL	$6.51 - $9.6 $25,252 - $37,238	-3,879 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$5.52 - $7.99 $18,790 - $27,197	-3,404 Reduced 46.74%	3,879 $30,000
Q2 2018 Aug 14, 2018	BUY	$4.6 - $6.52 $19,757 - $28,003	4,295 Added 143.74%	7,283 $42,000
Q1 2018 May 11, 2018	BUY	$4.35 - $5.82 $6,933 - $9,277	1,594 Added 114.35%	2,988 $14,000
Q4 2017 Feb 09, 2018	SELL	$4.16 - $5.33 $191,247 - $245,036	-45,973 Reduced 97.06%	1,394 $7,000
Q3 2017 Nov 15, 2017	BUY	$4.1 - $5.97 $194,204 - $282,780	47,367	47,367 $248,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$156 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$153 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$91 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69.7 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.9 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account